Primary Site >> Liver Cancer

Gene >> SALL4

Journal: Am J Surg Pathol. 2010 Apr;34(4):533-40.
Title: SALL4 represents fetal gut differentiation of gastric cancer, and is diagnostically useful in distinguishing hepatoid gastric carcinoma from hepatocellular carcinoma.
Author: Ushiku, Tetsuo|Shinozaki, Aya|Shibahara, Junji|Iwasaki, Yoshiaki|Tateishi, Yoko|Funata, Nobuaki|Fukayama, Masashi
PMID: 20182341
Journal: Hum Pathol. 2012 Nov;43(11):1955-63.
Title: alpha-Fetoprotein-producing gastric carcinoma and combined hepatocellular and cholangiocarcinoma show similar morphology but different histogenesis with respect to SALL4 expression.
Author: Ikeda, Hiroko|Sato, Yasunori|Yoneda, Norihide|Harada, Kenichi|Sasaki, Motoko|Kitamura, Seiko|Sudo, Yoshiko|Ooi, Akishi|Nakanuma, Yasuni
PMID: 22516245
Journal: Hum Pathol. 2013 Jul;44(7):1293-9.
Title: Immunohistochemical expression of SALL4 in hepatocellular carcinoma, a potential pitfall in the differential diagnosis of yolk sac tumors.
Author: Gonzalez-Roibon, Nilda|Katz, Betina|Chaux, Alcides|Sharma, Rajni|Munari, Enrico|Faraj, Sheila F|Illei, Peter B|Torbenson, Michael|Netto, George J
PMID: 23347651
Journal: Int J Surg Pathol. 2013 Dec;21(6):553-72.
Title: Newly available antibodies with practical applications in surgical pathology.
Author: Chan, John K C
PMID: 24225578
Journal: N Engl J Med. 2013 Sep 19;369(12):1171.
Title: Oncofetal gene SALL4 in aggressive hepatocellular carcinoma.
Author: Masuda, Shigeo|Suzuki, Keiichiro|Izpisua Belmonte, Juan Carlos
PMID: 24047071
Journal: N Engl J Med. 2013 Sep 19;369(12):1170-1.
Title: Oncofetal gene SALL4 in aggressive hepatocellular carcinoma.
Author: Suzuki, Eiichiro|Chiba, Tetsuhiro|Yokosuka, Osamu
PMID: 24047070
Journal: N Engl J Med. 2013 Sep 19;369(12):1170.
Title: Oncofetal gene SALL4 in aggressive hepatocellular carcinoma.
Author: Hopkins, Laurence J|Rowe, Ian A C|Houlihan, Diarmaid D
PMID: 24047069
Journal: N Engl J Med. 2013 Sep 19;369(12):1171-2.
Title: Oncofetal gene SALL4 in aggressive hepatocellular carcinoma.
Author: Yong, Kol Jia|Chai, Li|Tenen, Daniel G
PMID: 24047068
Journal: Nat Rev Clin Oncol. 2013 Aug;10(8):426.
Title: Liver cancer: SALL4--a cancer marker and target.
Author: Jones, Bryony
PMID: 23799373
Journal: Nat Rev Gastroenterol Hepatol. 2013 Aug;10(8):441.
Title: Cancer: Importance of oncofetal gene, SALL4, in a subset of hepatocellular carcinoma.
Author: Leake, Isobel
PMID: 23797869
Journal: N Engl J Med. 2013 Jun 13;368(24):2266-76.
Title: Oncofetal gene SALL4 in aggressive hepatocellular carcinoma.
Author: Yong, Kol Jia|Gao, Chong|Lim, Joline S J|Yan, Benedict|Yang, Henry|Dimitrov, Todor|Kawasaki, Akira|Ong, Chee Wee|Wong, Kwong-Fai|Lee, Sanghoon|Ravikumar, Sharada|Srivastava, Supriya|Tian, Xi|Poon, Ronnie T|Fan, Sheung Tat|Luk, John M|Dan, Yock Young|Salto
PMID: 23758232
Journal: Hepatology. 2013 Apr;57(4):1469-83.
Title: Sal-like protein 4 (SALL4), a stem cell biomarker in liver cancers.
Author: Oikawa, Tsunekazu|Kamiya, Akihide|Zeniya, Mikio|Chikada, Hiromi|Hyuck, Ahn Dong|Yamazaki, Yuji|Wauthier, Eliane|Tajiri, Hisao|Miller, Lance D|Wang, Xin Wei|Reid, Lola M|Nakauchi, Hiromitsu
PMID: 23175232
Journal: J Hepatol. 2014 Jan;60(1):127-34.
Title: The transcription factor SALL4 regulates stemness of EpCAM-positive hepatocellular carcinoma.
Author: Zeng, Sha Sha|Yamashita, Taro|Kondo, Mitsumasa|Nio, Kouki|Hayashi, Takehiro|Hara, Yasumasa|Nomura, Yoshimoto|Yoshida, Mariko|Hayashi, Tomoyuki|Oishi, Naoki|Ikeda, Hiroko|Honda, Masao|Kaneko, Shuichi
PMID: 24012616
Journal: Am J Surg Pathol. 2014 Jul;38(7):966-72.
Title: SALL4 immunoreactivity predicts prognosis in Western hepatocellular carcinoma patients but is a rare event: a study of 236 cases.
Author: Liu, Ta-Chiang|Vachharajani, Neeta|Chapman, William C|Brunt, Elizabeth M
PMID: 24805857
Journal: J Immunol Res. 2014;2014:262385.
Title: Serum SALL4 is a novel prognosis biomarker with tumor recurrence and poor survival of patients in hepatocellular carcinoma.
Author: Han, Su-xia|Wang, Jun-lan|Guo, Xi-jing|He, Chen-chen|Ying, Xia|Ma, Jin-lu|Zhang, Yuan-yuan|Zhao, Qian|Zhu, Qing
PMID: 24860834
Journal: Int J Gynecol Pathol. 2014 Jul;33(4):365-73.
Title: Gonadoblastoma and hepatoid and endometrioid-like yolk sac tumor: an update.
Author: Ulbright, Thomas M
PMID: 24901396
Journal: Liver Cancer. 2014 May;3(2):71-84.
Title: Molecular biology of liver cancer stem cells.
Author: Oishi, Naoki|Yamashita, Taro|Kaneko, Shuichi
PMID: 24944998
Journal: Springerplus. 2014 Dec 10;3:721.
Title: Clinicopathologic characteristics of SALL4-immunopositive hepatocellular carcinoma.
Author: Shibahara, Junji|Ando, Sumiyo|Hayashi, Akimasa|Sakamoto, Yoshihiro|Hesegawa, Kiyoshi|Kokudo, Norihiro|Fukayama, Masashi
PMID: 26034695
Journal: Oncotarget. 2015 Sep 29;6(29):27416-26.
Title: SALL4 is a novel therapeutic target in intrahepatic cholangiocarcinoma.
Author: Deng, Gang|Zhu, Lei|Huang, Feizhou|Nie, Wanpin|Huang, Wei|Xu, Hongbo|Zheng, Shaopeng|Yi, Zhongjie|Wan, Tao
PMID: 26317546
Journal: Virchows Arch. 2015 Nov;467(5):535-42.
Title: beta-catenin alteration is rare in hepatocellular carcinoma with steatohepatitic features: immunohistochemical and mutational study.
Author: Ando, Sumiyo|Shibahara, Junji|Hayashi, Akimasa|Fukayama, Masashi
PMID: 26311355
Journal: J Pathol Transl Med. 2015 Sep;49(5):373-81.
Title: SALL4 Expression in Hepatocellular Carcinomas Is Associated with EpCAM-Positivity and a Poor Prognosis.
Author: Park, Hyunjin|Lee, Hyejung|Seo, An Na|Cho, Jai Young|Choi, Young Rok|Yoon, Yoo-Seok|Han, Ho-Seong|Park, Young Nyun|Kim, Haeryoung
PMID: 26265684
Journal: Histopathology. 2016 Apr;68(5):693-701.
Title: Spalt-like transcription factor 4 immunopositivity is associated with epithelial cell adhesion molecule expression in combined hepatocellular carcinoma and cholangiocarcinoma.
Author: Tanaka, Yuki|Aishima, Shinichi|Kohashi, Kenichi|Okumura, Yukihiko|Wang, Huanlin|Hida, Tomoyuki|Kotoh, Kazuhiro|Shirabe, Ken|Maehara, Yoshihiko|Takayanagi, Ryoichi|Oda, Yoshinao
PMID: 26267070
Journal: Int J Mol Med. 2016 Nov;38(5):1587-1595.
Title: MicroRNA-33b suppresses the proliferation and metastasis of hepatocellular carcinoma cells through the inhibition of Sal-like protein 4 expression.
Author: Tian, Qinggang|Xiao, Yao|Wu, Yanting|Liu, Yun|Song, Zhiqing|Gao, Wenfeng|Zhang, Jing|Yang, Jingling|Zhang, Yuguo|Guo, Tuankui|Dai, Furong|Sun, Zhigang
PMID: 28026002
Journal: Zhonghua Gan Zang Bing Za Zhi. 2016 Jul 20;24(7):500-505.
Title: [Expression of sal-like 4 in primary hepatocellular carcinoma and its association with epithelial-mesenchymal transition].
Author: Xu, J|Wang, J|Hu, Y|Wang, X X|Cheng, L L|Yu, H Y
PMID: 27784427
Journal: Sci Rep. 2016 Oct 11;6:34856.
Title: Hepatocellular Carcinoma-propagating Cells are Detectable by Side Population Analysis and Possess an Expression Profile Reflective of a Primitive Origin.
Author: Xia, Honghai|Cao, Jun|Li, Qing|Lv, Yang|Jia, Weidong|Ren, Weihua|Cheng, Qingyu|Song, Xiaoyuan|Xu, Geliang
PMID: 27725724
Journal: Oncotarget. 2016 Nov 8;7(45):74059-74073.
Title: MicroRNA-98 acts as a tumor suppressor in hepatocellular carcinoma via targeting SALL4.
Author: Zhou, Wuyuan|Zou, Benkui|Liu, Lisheng|Cui, Kai|Gao, Jie|Yuan, Shuanghu|Cong, Ning
PMID: 27677076
Journal: Zhong Nan Da Xue Xue Bao Yi Xue Ban. 2016 Sep 28;41(9):905-10.
Title: [MicroRNA-33b inhibits cell proliferation in hepatocellular carcinoma via targeting SALL4].
Author: Li, Yan|Li, Ronghua|Fu, Xiaoyu|Zhou, Wei|Peng, Shifang|Fu, Lei
PMID: 27640788
Journal: Ann Surg Treat Res. 2016 Jul;91(1):23-8.
Title: Positive immunostaining of Sal-like protein 4 is associated with poor patient survival outcome in the large and undifferentiated Korean hepatocellular carcinoma.
Author: Jung, Yun Kyung|Jang, Kiseok|Paik, Seung Sam|Kwon, Yong Jin|Kim, Han Jun|Lee, Kyeong Geun|Park, Hwon Kyum|Choi, Dongho
PMID: 27433461
Journal: World J Gastroenterol. 2016 Mar 7;22(9):2837-43.
Title: Importance of SALL4 in the development and prognosis of hepatocellular carcinoma.
Author: Yin, Fei|Han, Xin|Yao, Shu-Kun|Wang, Xiao-Ling|Yang, Hui-Chai
PMID: 26973422
Journal: Tumour Biol. 2016 Aug;37(8):10943-58.
Title: Combination of 5-fluorouracil and 2-morphilino-8-phenyl-4H-chromen-4-one may inhibit liver cancer stem cell activity.
Author: Peng, Yu-Chong|Lu, Shi-Dong|Zhong, Jian-Hong|Xie, Zhi-Bo|You, Xue-Mei|Peng, Ning-Fu|Li, Le-Qun
PMID: 26886287
Journal: Oncogene. 2017 Apr 27;36(17):2435-2445.
Title: DNA demethylation induces SALL4 gene re-expression in subgroups of hepatocellular carcinoma associated with Hepatitis B or C virus infection.
Author: Fan, H|Cui, Z|Zhang, H|Mani, S K|Diab, A|Lefrancois, L|Fares, N|Merle, P|Andrisani, O
PMID: 27797380
Journal: J Hepatol. 2017 May;66(5):952-961.
Title: Mixed hepatocellular cholangiocarcinoma tumors: Cholangiolocellular carcinoma is a distinct molecular entity.
Author: Moeini, Agrin|Sia, Daniela|Zhang, Zhongyang|Camprecios, Genis|Stueck, Ashley|Dong, Hui|Montal, Robert|Torrens, Laura|Martinez-Quetglas, Iris|Fiel, M Isabel|Hao, Ke|Villanueva, Augusto|Thung, Swan N|Schwartz, Myron E|Llovet, Josep M
PMID: 28126467
Journal: Hum Pathol. 2017 Jun;64:69-75.
Title: Coexpression of SALL4 with HDAC1 and/or HDAC2 is associated with underexpression of PTEN and poor prognosis in patients with hepatocellular carcinoma.
Author: Wang, Huanlin|Kohashi, Kenichi|Yoshizumi, Tomoharu|Okumura, Yukihiko|Tanaka, Yuki|Shimokawa, Masahiro|Iwasaki, Takeshi|Aishima, Shinichi|Maehara, Yoshihiko|Oda, Yoshinao
PMID: 28411180
Journal: BMC Complement Altern Med. 2018 Mar 20;18(1):99.
Title: Extract of Stellerachamaejasme L(ESC) inhibits growth and metastasis of human hepatocellular carcinoma via regulating microRNA expression.
Author: Liu, Xiaoni|Wang, Shuang|Xu, Jianji|Kou, Buxin|Chen, Dexi|Wang, Yajie|Zhu, Xiaoxin
PMID: 29554896
Journal: Nat Commun. 2018 Mar 28;9(1):1241.
Title: Oncofetal gene SALL4 reactivation by hepatitis B virus counteracts miR-200c in PD-L1-induced T cell exhaustion.
Author: Sun, Cheng|Lan, Peixiang|Han, Qiuju|Huang, Mei|Zhang, Zhihong|Xu, Geliang|Song, Jiaxi|Wang, Jinyu|Wei, Haiming|Zhang, Jian|Sun, Rui|Zhang, Cai|Tian, Zhigang
PMID: 29593314
Journal: Hepatology. 2018 Sep;68(3):1025-1041.
Title: Landscape of immune microenvironment in hepatocellular carcinoma and its additional impact on histological and molecular classification.
Author: Kurebayashi, Yutaka|Ojima, Hidenori|Tsujikawa, Hanako|Kubota, Naoto|Maehara, Junki|Abe, Yuta|Kitago, Minoru|Shinoda, Masahiro|Kitagawa, Yuko|Sakamoto, Michiie
PMID: 29603348
Journal: Proc Natl Acad Sci U S A. 2018 Jul 24;115(30):E7119-E7128.
Title: Targeting cancer addiction for SALL4 by shifting its transcriptome with a pharmacologic peptide.
Author: Liu, Bee Hui|Jobichen, Chacko|Chia, C S Brian|Chan, Tim Hon Man|Tang, Jing Ping|Chung, Theodora X Y|Li, Jia|Poulsen, Anders|Hung, Alvin W|Koh-Stenta, Xiaoying|Tan, Yaw Sing|Verma, Chandra S|Tan, Hong Kee|Wu, Chan-Shuo|Li, Feng|Hill, Jeffrey|Joy, Joma|Yang
PMID: 29976840
Journal: Pathol Res Pract. 2018 Oct;214(10):1707-1712.
Title: Expression of RNA-binding protein LIN28 in classic gastric hepatoid carcinomas, gastric fetal type gastrointestinal adenocarcinomas, and hepatocellular carcinomas: An immunohistochemical study with comparison to SALL4, alpha-fetoprotein, glypican-3, and H
Author: Zhao, Ming|Sun, Lu|Lai, Jenny Z|Shi, Huaiyin|Mei, Kaiyong|He, Xianglei|Jin, Xiaolong|Lai, Jinping|Cao, Dengfeng
PMID: 30196987